Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care toda... Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. Show more
Inspiraβ’ Announces Business Plan Targets PR Newswire RA'ANANA, Israel, June 20, 2024 Company to aggressively promote INSPIRAβ’Β ART100 in the U.S. and additional markets following FDA clearance, as...
Inspiraβ’ Introduces Advanced Life Support Solutions to Key International Leaders at the Annual iECOs Conference in Israel PR Newswire RA'ANANA, Israel, June 17, 2024 RA'ANANA, Israel, June 17...
Inspiraβ’ Receives First Ever Purchase Order for INSPIRAβ’ ART100 Systems in the U.S. PR Newswire RA'ANANA, Israel, June 13, 2024 First units expected to be shipped in Q4 2024. The Purchase Order...
Inspiraβ’ to Exhibit the FDA Cleared INSPIRAβ’ ART100 System at a World-Renowned Event in the Sector PR Newswire RA'ANANA, Israel, June 5, 2024 The event is an opportunity to present and...
Inspiraβ’ Technologies Announces Business Targets Presentation Following FDA Clearance and Significant Developments PR Newswire RA'ANANA, Israel, May 30, 2024 RA'ANANA, Israel, May 30, 2024...
INSPIRAβ’ ART100 Receives FDA 510(k) Clearance PR Newswire RA'ANANA, Israel, May 28, 2024 RA'ANANA, Israel, May 28, 2024 /PRNewswire/ -- Inspiraβ’ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN...
Inspiraβ’ Announces Start of Production of the INSPIRAβ’ ART100 PR Newswire RA'ANANA, Israel, May 2, 2024 RA'ANANA, Israel, May 2, 2024 /PRNewswire/ --Β Inspiraβ’Β Technologies OXY B.H.N. Ltd...
Inspiraβ’ Receives CSA Certification of Compliance to U.S. Standards for the INSPIRAβ’ ART100 PR Newswire RA'ANANA, Israel, April 25, 2024 RA'ANANA, Israel, April 25, 2024 /PRNewswire/ -- Inspiraβ’...
Inspiraβ’ Signs Term Sheet for Use of INSPIRAβ’ ART100 Device in Organ Transplant Procedures PR Newswire RA'ANANA, Israel, April 16, 2024 RA'ANANA, Israel, April 16, 2024 /PRNewswire/ --Β Inspiraβ’...
Inspiraβ’ and Ennocure In Vitro Study Results Show 100% Prevention of Bacterial Growth that Causes Bloodstream Infections PR Newswire RA'ANANA, Israel, April 10, 2024 RA'ANANA, Israel, April 10...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.51 | -26.7015706806 | 1.91 | 2.02 | 1.32 | 178943 | 1.56200549 | CS |
4 | -0.72 | -33.9622641509 | 2.12 | 2.44 | 1.32 | 157243 | 1.96160288 | CS |
12 | -0.36 | -20.4545454545 | 1.76 | 2.44 | 1.32 | 184684 | 2.02068094 | CS |
26 | 0.28 | 25 | 1.12 | 2.49 | 0.7613 | 1001195 | 1.36118517 | CS |
52 | -0.15 | -9.67741935484 | 1.55 | 2.49 | 0.7613 | 505789 | 1.35957302 | CS |
156 | -3.6 | -72 | 5 | 9.59 | 0.7613 | 1267926 | 4.41384697 | CS |
260 | -3.6 | -72 | 5 | 9.59 | 0.7613 | 1267926 | 4.41384697 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.